Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people

被引:11
作者
Boot, Hein J. [1 ]
Sonsma, Jan [1 ]
van Nunen, Femke [1 ]
Abbink, Frithjofna [1 ]
Kimman, Tjeerd G. [1 ]
Buisman, Anne-Marie [1 ]
机构
[1] Natl Inst Publ Hlth & Environm, Lab Vaccine Prevent Dis, NL-3720 BA Bilthoven, Netherlands
关键词
monovalent oral poliovirus vaccine; vaccine-derived poliovirus; mutation analysis;
D O I
10.1016/j.vaccine.2007.04.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Live oral poliovirus vaccine (OPV) strains can mutate and recombine during replication in the host. Trivalent OPV has long been used to restrain wild-type poliovirus in developing countries. However, recently WHO advocates using monovalent OPV (mOPV) to finally eradicate poliovirus world-wide. We analysed polioviruses recovered from the faeces of 101 elderly patients (divided into three groups by immune status) challenged with mOPV-1 or mOPV-3. A high number of nucleotide mutations was found in the viral capsid-protein-encoding regions. Some of these mutations caused amino acid changes in or near regions with neutralizing epitopes, especially in mOPV-1-derived strains. The quantities of mutations in recovered poliovirus, strains correlated with prevaccination immune status (seronegatives have more mutations) and excretion duration. Duration of excretion appears to be the dominant factor for the accumulation of mutations in mOPV-derived strains in vaccinated elderly people. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4706 / 4714
页数:9
相关论文
共 24 条
[1]   Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion [J].
Abbink, F ;
Buisman, AM ;
Doornbos, G ;
Woldman, J ;
Kimman, TG ;
Conyn-van Spaendonck, MAE .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (06) :990-999
[2]  
Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1093
[3]  
Bijkerk H, 1978, Ned Tijdschr Geneeskd, V122, P885
[4]   Identification, phenotypic analysis, and full-length nucleotide sequence of a Dutch coxsackievirus A20 isolate [J].
Boot, Hein J. ;
Lukashov, Vladimir V. ;
van Remmerden, Yvonne ;
Kimman, Tjeerd G. .
VIRUS GENES, 2007, 34 (01) :75-85
[5]   Rapid RT-PCR amplification of full-length poliovirus genomes allows rapid discrimination between wild-type and recombinant vaccine-derived polioviruses [J].
Boot, HJ ;
Schepp, RA ;
van Nunen, FJHB ;
Kimman, TG .
JOURNAL OF VIROLOGICAL METHODS, 2004, 116 (01) :35-43
[6]   Excretion of wild-type and vaccine-derived poliovirus in the feces of poliovirus receptor-transgenic mice [J].
Boot, HJ ;
Kasteel, DTJ ;
Buisman, AM ;
Kimman, TG .
JOURNAL OF VIROLOGY, 2003, 77 (11) :6541-6545
[7]   DETERMINANTS OF ATTENUATION AND TEMPERATURE SENSITIVITY IN THE TYPE-1 POLIOVIRUS SABIN VACCINE [J].
BOUCHARD, MJ ;
LAM, DH ;
RACANIELLO, VR .
JOURNAL OF VIROLOGY, 1995, 69 (08) :4972-4978
[8]   Sabin monovalent oral polio vaccines:: Review of past experiences and their potential use after polio eradication [J].
Cáceres, VM ;
Sutter, RW .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :531-541
[9]  
*CDC, 2005, MMWR-MORBID MORTAL W, V54, P1186
[10]   Vaccine-derived polioviruses: Is it time to stop using the word "rare"? [J].
Dowdle, Walter ;
Kew, Olen .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (05) :539-541